Splenomegaly (enlarged spleen)

Last updated: 7 September 2026
Reviewed by: Specialist doctors from the Elfcare quality team

A dull ache or feeling of fullness in the upper left side of your abdomen, especially after eating only a small amount, can be a sign of an enlarged spleen. So can persistent fatigue, easy bruising or bleeding, or infections that seem to happen more often than usual. Splenomegaly is an enlargement of the spleen and is usually a sign of another condition that needs to be investigated.

Splenomegaly is one of the most commonly identified incidental findings on abdominal MRI, frequently discovered in people who had no idea their spleen was enlarged. It is not a diagnosis in itself but a clinical finding that demands investigation of its cause, as the underlying condition determines both prognosis and treatment.

Book a consultation now to test your health

What is splenomegaly?

Splenomegaly is an enlarged spleen, typically defined in adults as a spleen measuring more than about 12–13 cm in length on imaging. Located in the upper left abdomen, the spleen filters damaged blood cells, stores platelets, and fights off infections.

Doctors classify an enlarged spleen by the underlying mechanism driving it:

  • Congestive: caused by high blood pressure in the liver (portal hypertension) or veins, which forces blood to back up and pool inside the spleen like a clogged sponge.

  • Infiltrative: caused by a buildup of abnormal cells or materials, such as cancer cells in leukemia and lymphoma, or unusual proteins in rare metabolic storage disorders.

  • Immune and Inflammatory: caused by the spleen overworking its immune defenses, which triggers tissue swelling during viral infections (like glandular fever) or chronic autoimmune diseases.

  • Haematological: caused by the spleen working overtime to destroy massive amounts of damaged red blood cells, or trying to generate new blood cells because the bone marrow is failing.

Symptoms of splenomegaly

Many people with splenomegaly have no symptoms and only discover it during abdominal imaging performed for another reason. When symptoms do occur, they may reflect the enlarged spleen itself or the condition causing it:

  • Left upper quadrant discomfort, fullness, or a dull aching pain, often worse after eating

  • Early satiety from the enlarged spleen compressing the stomach

  • Referred pain to the left shoulder from diaphragmatic irritation

  • Fatigue and weakness from anaemia caused by increased red cell destruction or bone marrow suppression

  • Increased susceptibility to infection from splenic dysfunction or underlying immune impairment

  • Easy bruising and bleeding from thrombocytopenia, as an enlarged spleen sequesters platelets excessively

  • Symptoms of the underlying condition, including jaundice in haemolytic anaemia or liver disease, night sweats and weight loss in lymphoma, or peripheral oedema in heart failure

Splenic rupture, though uncommon, is the most serious acute complication of splenomegaly and can be spontaneous in massive enlargement. Sudden severe left upper quadrant pain with haemodynamic instability is a medical emergency.

What causes splenomegaly?

Splenomegaly results from diverse underlying conditions affecting the spleen through different mechanisms. Common contributing causes include:

  • Liver disease: cirrhosis and high portal blood pressure force blood backward into the spleen, causing severe congestion and swelling.

  • Blood cancers: lymphoma and leukemia (like CML or myelofibrosis) flood the spleen with malignant cells, often causing massive enlargement.

  • Viral infections: conditions like Epstein-Barr virus (glandular fever), HIV, and hepatitis trigger a temporary, immune-driven swelling.

  • Autoimmune conditions: diseases like lupus, rheumatoid arthritis, or hemolytic anemia cause chronic inflammation or force the spleen to destroy too many red blood cells.

  • Heart failure: right-sided heart failure causes venous blood to back up into abdominal organs, congesting the spleen.

  • Genetic and metabolic disorders: conditions like sickle cell anemia, thalassemia, or Gaucher's disease overwork the spleen or cause cellular debris to accumulate inside it.

  • Tropical infections: globally, widespread parasitic infections like malaria are leading drivers of extreme spleen enlargement.

How is splenomegaly detected?

Splenomegaly is detected through abdominal imaging, with blood tests identifying the underlying systemic conditions most commonly responsible.

Abdominal MRI Elfcare’s full-body MRI includes the spleen as part of the standard abdominal examination. It can measure spleen size, assess its appearance, and identify findings such as focal lesions, infarcts, or other changes that may help guide further investigation.

Blood tests are essential for identifying the systemic conditions causing splenomegaly and assessing its haematological consequences. Relevant markers in Elfcare's panel include:

  • Full blood count and differential: checks for low red or white blood cells to pinpoint infections, viral illnesses, or bone marrow disorders.

  • Liver function profile (ALT, AST, GGT, ALP, albumin, bilirubin): screens for liver cirrhosis and high portal blood pressure, the most common causes of spleen swelling.

  • Platelet count: catches low platelets (thrombocytopenia), a primary sign that an enlarged spleen is trapping and pooling blood cells.

  • CRP and ferritin: measures systemic inflammation driven by active infections, autoimmune flares, or blood disorders.

  • Uric acid: evaluates rapid cell turnover, which frequently occurs with hidden blood cancers.

  • Haemoglobin, MCV and reticulocyte count: evaluates whether the spleen is prematurely destroying its own red blood cells (hemolytic anemia).

  • NT-proBNP: a specialized cardiac marker used to rule out heart failure as the source of fluid backup.

  • HbA1c and glucose: provides an essential baseline of your overall metabolic and blood sugar health.

Why early detection matters

Splenomegaly is a sign, not a diagnosis, and its clinical significance is entirely determined by its underlying cause. Identifying it early, before the underlying condition has progressed, allows for investigation and treatment that can prevent serious complications such as managing liver disease before dangerous internal bleeding occurs, or staging blood cancers at their most treatable phase. Crucially, early detection helps prevent a life-threatening splenic rupture and allows time for protective vaccinations if the spleen’s immune function begins to fail.

How Elfcare can help

Elfcare's full body MRI images the spleen directly as part of the standard abdominal sequence, measuring splenic dimensions and assessing morphology, focal lesions, and coexisting abdominal findings that together identify the most likely underlying cause. Splenomegaly identified incidentally on Elfcare's abdominal MRI is a clinically important finding that initiates a systematic investigation pathway.

Our blood panel covers full blood count, liver function, CRP, ferritin, uric acid, NT-proBNP, and metabolic markers, providing the systemic picture needed to identify the most common underlying conditions and assess the haematological consequences of splenic enlargement.

If our MRI or blood tests identify splenomegaly or related findings, we take care of further diagnostics or refer you to the appropriate specialist.

Book a consultation to learn more

Summary

Splenomegaly is an enlargement of the spleen beyond its normal dimensions that is almost always a sign of an underlying systemic condition, most commonly liver cirrhosis, haematological malignancy, viral infection, or autoimmune disease. Elfcare's full body MRI images the spleen directly, measuring its dimensions and identifying coexisting abdominal findings that point to the underlying cause, while our blood panel covers full blood count, liver function, inflammatory markers, and cardiac markers. Early identification of splenomegaly and the condition driving it provides the opportunity for targeted treatment before serious complications including haematological failure, variceal bleeding, or splenic rupture develop, protecting long-term health and organ function.

Last updated: 7 September 2026
Reviewed by: Specialist doctors from the Elfcare quality team

FAQ

  • Splenomegaly is an enlargement of the spleen beyond its normal length of approximately 11 cm, defined on imaging as a splenic length exceeding 13 cm. It is not a diagnosis in itself but a clinical finding reflecting an underlying systemic condition. Common causes include liver cirrhosis, haematological malignancies, viral infections, autoimmune conditions, and heart failure. The degree of enlargement and associated findings guide the investigation pathway.

  • Left upper quadrant discomfort or fullness, early satiety, fatigue from anaemia, easy bruising from thrombocytopenia, and increased infection susceptibility. Many cases cause no symptoms and are discovered incidentally on imaging. Sudden severe left upper quadrant pain may indicate splenic rupture, a medical emergency requiring immediate attention.

  • Liver cirrhosis and portal hypertension is the most common cause in developed countries. Haematological malignancies including lymphoma, leukaemia, and myelofibrosis, viral infections including Epstein-Barr virus, autoimmune conditions, heart failure, haemoglobinopathies, and metabolic storage disorders are other important causes. The mechanism differs between congestive, infiltrative, immune, and haematological splenomegaly.

  • Abdominal MRI directly measures splenic dimensions, assesses morphology, identifies focal lesions, and identifies coexisting abdominal findings pointing to the underlying cause. Blood tests covering full blood count, liver function, CRP, ferritin, and LDH identify the systemic conditions responsible and assess haematological consequences.

  • Yes. Elfcare's full body MRI images the spleen directly as part of the standard abdominal sequence, measuring dimensions and assessing for coexisting findings. Our blood panel covers full blood count, liver function, inflammatory markers, and cardiac markers. If splenomegaly or related findings are identified, we take care of further diagnostics or refer you to the appropriate specialist.

  • Treatment targets the underlying cause rather than the spleen itself. Portal hypertension from cirrhosis is managed with beta-blockers, endoscopic variceal treatment, and TIPS procedure in refractory cases. Haematological malignancies are treated with chemotherapy, immunotherapy, or targeted agents depending on type and stage. Viral splenomegaly resolves with treatment of the infection. Autoimmune causes respond to immunosuppressive therapy. Splenectomy is reserved for refractory haemolysis, symptomatic massive splenomegaly unresponsive to medical treatment, and selected haematological conditions. Early identification of the underlying cause and appropriate management prevents the serious complications of untreated progressive splenomegaly.